XMT-2056

· Mersana Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XMT-2056, covering 2025-07-11 to 2025-07-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 [Phase 1]